DK3131585T3 - MULTIDENTATE, BY-FUNCTIONAL CHELATING AGENTS FOR RADIONUCLID COMPLEX FORMATION IN DIAGNOSTICS AND THERAPY - Google Patents
MULTIDENTATE, BY-FUNCTIONAL CHELATING AGENTS FOR RADIONUCLID COMPLEX FORMATION IN DIAGNOSTICS AND THERAPY Download PDFInfo
- Publication number
- DK3131585T3 DK3131585T3 DK15710778.0T DK15710778T DK3131585T3 DK 3131585 T3 DK3131585 T3 DK 3131585T3 DK 15710778 T DK15710778 T DK 15710778T DK 3131585 T3 DK3131585 T3 DK 3131585T3
- Authority
- DK
- Denmark
- Prior art keywords
- radionuclid
- multidentate
- diagnostics
- therapy
- chelating agents
- Prior art date
Links
- 0 CCCC[C@@](*C(C(CC(C)C)*C([C@](CC(*=CC)=CC)*C(C*C(C(*C([C@](C)*C([C@](CC1=C*c2ccccc12)*C([C@](CCC(*)=O)C(C(CC*C(CC*C(CC*C(CCC(*CCCCC*(C(CCC(*CCCCC*(C(CCC(*CCCCCC(C(CCC(*CCCCC*(C(C)=O)O)=O)=O)O)=O)=O)O)=O)=O)O)=I=C)=O)=O)=O)=O)=C)=O)=O)=*)C(C)C)=O)=O)=O)=O)C(*)=O Chemical compound CCCC[C@@](*C(C(CC(C)C)*C([C@](CC(*=CC)=CC)*C(C*C(C(*C([C@](C)*C([C@](CC1=C*c2ccccc12)*C([C@](CCC(*)=O)C(C(CC*C(CC*C(CC*C(CCC(*CCCCC*(C(CCC(*CCCCC*(C(CCC(*CCCCCC(C(CCC(*CCCCC*(C(C)=O)O)=O)=O)O)=O)=O)O)=O)=O)O)=I=C)=O)=O)=O)=O)=C)=O)=O)=*)C(C)C)=O)=O)=O)=O)C(*)=O 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
- C07C235/74—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
- C07F7/003—Compounds containing elements of Groups 4 or 14 of the Periodic System without C-Metal linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
- C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
- C08G69/08—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
- C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
- C08G69/08—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
- C08G69/10—Alpha-amino-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
- C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
- C08G69/26—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from polyamines and polycarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
- C08G69/48—Polymers modified by chemical after-treatment
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14160792 | 2014-03-19 | ||
| PCT/EP2015/055684 WO2015140212A1 (en) | 2014-03-19 | 2015-03-18 | Multidentate bifunctional chelating agents for radionuclide complexation in diagnostics and therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3131585T3 true DK3131585T3 (en) | 2020-10-19 |
Family
ID=50289571
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15710778.0T DK3131585T3 (en) | 2014-03-19 | 2015-03-18 | MULTIDENTATE, BY-FUNCTIONAL CHELATING AGENTS FOR RADIONUCLID COMPLEX FORMATION IN DIAGNOSTICS AND THERAPY |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11033642B2 (en) |
| EP (1) | EP3131585B1 (en) |
| DK (1) | DK3131585T3 (en) |
| ES (1) | ES2824674T3 (en) |
| HU (1) | HUE050988T2 (en) |
| PT (1) | PT3131585T (en) |
| WO (1) | WO2015140212A1 (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017096430A1 (en) * | 2015-12-09 | 2017-06-15 | The University Of Sydney | Hydroxamic acid-based compounds |
| CN106008256B (en) * | 2016-06-01 | 2018-11-09 | 上海市伤骨科研究所 | A kind of derivative compound and its preparation method and application of desferrioxamining with bone affinity |
| TWI782930B (en) | 2016-11-16 | 2022-11-11 | 美商再生元醫藥公司 | Anti-met antibodies, bispecific antigen binding molecules that bind met, and methods of use thereof |
| WO2018102682A1 (en) | 2016-12-01 | 2018-06-07 | Regeneron Pharmaceuticals, Inc. | Radiolabeled anti-pd-l1 antibodies for immuno-pet imaging |
| CN110650974B (en) | 2017-02-10 | 2024-04-19 | 瑞泽恩制药公司 | Radiolabeled anti-LAG 3 antibodies for immune-PET imaging |
| AU2018307744A1 (en) | 2017-07-24 | 2020-02-13 | Regeneron Pharmaceuticals, Inc. | Anti-CD8 antibodies and uses thereof |
| JP2022537019A (en) | 2019-06-21 | 2022-08-23 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | Use of Bispecific Antigen Binding Molecules that Bind PSMA and CD3 in Combination with 4-1BB Costimulation |
| CA3140083A1 (en) | 2019-06-21 | 2020-12-24 | Regeneron Pharmaceuticals, Inc. | Use of bispecific antigen-binding molecules that bind muc16 and cd3 in combination with 4-1bb co-stimulation |
| CA3146933A1 (en) | 2019-09-16 | 2021-03-25 | Marcus KELLY | Radiolabeled met binding proteins for immuno-pet imaging |
| JP2023548975A (en) | 2020-11-10 | 2023-11-21 | レジェネロン ファーマシューティカルズ， インコーポレイテッド | Selenium antibody complex |
| WO2023224974A1 (en) * | 2022-05-20 | 2023-11-23 | Brookhaven Science Associates, Llc. | Alkyl-substituted hydroxamate resin for use in a generator system |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2337756A1 (en) * | 1998-07-23 | 2000-02-03 | Otto F. Schall | Libraries of polyhydroxamates and their analogs |
| GB0116815D0 (en) | 2001-07-10 | 2001-08-29 | Nycomed Amersham Plc | Improved chelator conjugates |
| US7728038B2 (en) * | 2004-08-04 | 2010-06-01 | University Of Utah Research Foundation | Methods for chelation therapy |
| US8309583B2 (en) * | 2007-11-01 | 2012-11-13 | Rachel Codd | Desferrioxamine conjugates, derivatives and analogues |
| EP2604281B1 (en) | 2011-12-14 | 2014-07-30 | Centre National de la Recherche Scientifique (CNRS) | Clicked somatostatin conjugated analogs for biological applications |
| WO2014164988A1 (en) * | 2013-03-13 | 2014-10-09 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Tetrahydroxamate chelators of zirconium89 and niobium90 for use in diagnostic applications |
-
2015
- 2015-03-18 EP EP15710778.0A patent/EP3131585B1/en active Active
- 2015-03-18 ES ES15710778T patent/ES2824674T3/en active Active
- 2015-03-18 US US15/127,025 patent/US11033642B2/en active Active
- 2015-03-18 PT PT157107780T patent/PT3131585T/en unknown
- 2015-03-18 DK DK15710778.0T patent/DK3131585T3/en active
- 2015-03-18 HU HUE15710778A patent/HUE050988T2/en unknown
- 2015-03-18 WO PCT/EP2015/055684 patent/WO2015140212A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| US20170106106A1 (en) | 2017-04-20 |
| EP3131585B1 (en) | 2020-07-15 |
| HUE050988T2 (en) | 2021-01-28 |
| ES2824674T3 (en) | 2021-05-13 |
| PT3131585T (en) | 2020-10-23 |
| WO2015140212A1 (en) | 2015-09-24 |
| EP3131585A1 (en) | 2017-02-22 |
| US11033642B2 (en) | 2021-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3131585T3 (en) | MULTIDENTATE, BY-FUNCTIONAL CHELATING AGENTS FOR RADIONUCLID COMPLEX FORMATION IN DIAGNOSTICS AND THERAPY | |
| DK3304616T3 (en) | Understøtningselement til et øvre hus i et batterisæt | |
| DK3161124T3 (en) | Endophytes, associated compositions and methods for their use | |
| DK3174874T3 (en) | Berberine salts, ursodeoxycholic salts and combinations, methods for their preparation and use. | |
| DK3227336T3 (en) | Anti-CD79b antibodies and methods for use | |
| DK3215147T3 (en) | NEUROTENANT NORKETAMINE COMPOUNDS AND METHODS | |
| GB201512203D0 (en) | Agents,uses and methods | |
| DK3113797T3 (en) | ANTIBODIES, USES AND METHODS | |
| HK1215827A1 (en) | Method and device for logging in through two-dimensional code | |
| DK3146035T3 (en) | Biofilm media, treatment system and treatment method | |
| DK3204386T3 (en) | SUBSTITUTED AMINOPURY COMPOUNDS, COMPOSITIONS THEREOF AND METHODS FOR TREATMENT THEREOF | |
| BR112017004332A2 (en) | profiles. | |
| HK1215900A1 (en) | Communication device and method for execution by the communication device | |
| DK3265123T3 (en) | ANTIBODIES, USES AND METHODS | |
| BR112016029236A2 (en) | methods for treating itching. | |
| GB201512215D0 (en) | Agents,uses and methods | |
| PL2980461T3 (en) | Check valves | |
| GB201411571D0 (en) | Radiolabelling method | |
| HK1224016A1 (en) | Method for determining diffusion | |
| DK3225616T3 (en) | ALPHA-ASARY LALDEHYESTER, PROCEDURE FOR PREPARING IT AND USING IT | |
| PL3152016T3 (en) | Method for manufacturing plywood and plywood | |
| DK3795130T3 (en) | THERAPY APPARATUS. | |
| DK3198005T3 (en) | PROCEDURES FOR IN VITRO-OOCYTE DEVELOPMENT | |
| DK2950059T3 (en) | LEVEL MEASURES AND LEVEL MEASURES | |
| DK3124611T3 (en) | APTAMS FOR FGF2 AND USE THEREOF |